JP Morgan Maintains Overweight on IDEXX Laboratories, Lowers Price Target to $750

Benzinga · 3d ago
JP Morgan analyst Chris Schott maintains IDEXX Laboratories (NASDAQ:IDXX) with a Overweight and lowers the price target from $775 to $750.